These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 37863321)

  • 1. Analysis of blood and nasal epithelial transcriptomes to identify mechanisms associated with control of SARS-CoV-2 viral load in the upper respiratory tract.
    Moradi Marjaneh M; Challenger JD; Salas A; Gómez-Carballa A; Sivananthan A; Rivero-Calle I; Barbeito-Castiñeiras G; Foo CY; Wu Y; Liew F; Jackson HR; Habgood-Coote D; D'Souza G; Nichols SJ; Wright VJ; Levin M; Kaforou M; Thwaites RS; Okell LC; Martinón-Torres F; Cunnington AJ; ;
    J Infect; 2023 Dec; 87(6):538-550. PubMed ID: 37863321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARS-CoV-2 infection and viral load are associated with the upper respiratory tract microbiome.
    Rosas-Salazar C; Kimura KS; Shilts MH; Strickland BA; Freeman MH; Wessinger BC; Gupta V; Brown HM; Rajagopala SV; Turner JH; Das SR
    J Allergy Clin Immunol; 2021 Apr; 147(4):1226-1233.e2. PubMed ID: 33577896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-CoV-2 viral load dynamics and real-time RT-PCR cycle threshold interpretation in symptomatic non-hospitalised individuals in New Zealand: a multicentre cross sectional observational study.
    Fox-Lewis A; Fox-Lewis S; Beaumont J; Drinković D; Harrower J; Howe K; Jackson C; Rahnama F; Shilton B; Qiao H; Smith KK; Morpeth SC; Taylor S; Blakiston M; Roberts S; McAuliffe G
    Pathology; 2021 Jun; 53(4):530-535. PubMed ID: 33838922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of Viral Load Cycle Threshold Values in Patients with SARS-CoV-2 Associated Pneumonia with Real-Time PCR Method.
    Bakir A; Hosbul T; Cuce F; Artuk C; Taskin G; Caglayan M; Guney M; Kurkcu MF; Yildiz F; Erdal H; Erdem G
    J Infect Dev Ctries; 2021 Oct; 15(10):1408-1414. PubMed ID: 34780363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucosal Gene Expression in Response to SARS-CoV-2 Is Associated with Viral Load.
    Rajagopala SV; Strickland BA; Pakala SB; Kimura KS; Shilts MH; Rosas-Salazar C; Brown HM; Freeman MH; Wessinger BC; Gupta V; Phillips E; Mallal SA; Turner JH; Das SR
    J Virol; 2023 Feb; 97(2):e0147822. PubMed ID: 36656015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modelling upper respiratory viral load dynamics of SARS-CoV-2.
    Challenger JD; Foo CY; Wu Y; Yan AWC; Marjaneh MM; Liew F; Thwaites RS; Okell LC; Cunnington AJ
    BMC Med; 2022 Jan; 20(1):25. PubMed ID: 35022051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association Between Upper Respiratory Tract Viral Load, Comorbidities, Disease Severity, and Outcome of Patients With SARS-CoV-2 Infection.
    Maltezou HC; Raftopoulos V; Vorou R; Papadima K; Mellou K; Spanakis N; Kossyvakis A; Gioula G; Exindari M; Froukala E; Martinez-Gonzalez B; Panayiotakopoulos G; Papa A; Mentis A; Tsakris A
    J Infect Dis; 2021 Apr; 223(7):1132-1138. PubMed ID: 33388780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2 shedding dynamics across the respiratory tract, sex, and disease severity for adult and pediatric COVID-19.
    Chen PZ; Bobrovitz N; Premji ZA; Koopmans M; Fisman DN; Gu FX
    Elife; 2021 Aug; 10():. PubMed ID: 34414888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spatial and temporal dynamics of SARS-CoV-2 in COVID-19 patients: A systematic review and meta-analysis.
    Weiss A; Jellingsø M; Sommer MOA
    EBioMedicine; 2020 Aug; 58():102916. PubMed ID: 32711256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-infection of SARS-CoV-2 with other respiratory viruses and performance of lower respiratory tract samples for the diagnosis of COVID-19.
    Burrel S; Hausfater P; Dres M; Pourcher V; Luyt CE; Teyssou E; Soulié C; Calvez V; Marcelin AG; Boutolleau D
    Int J Infect Dis; 2021 Jan; 102():10-13. PubMed ID: 33115679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo antiviral host transcriptional response to SARS-CoV-2 by viral load, sex, and age.
    Lieberman NAP; Peddu V; Xie H; Shrestha L; Huang ML; Mears MC; Cajimat MN; Bente DA; Shi PY; Bovier F; Roychoudhury P; Jerome KR; Moscona A; Porotto M; Greninger AL
    PLoS Biol; 2020 Sep; 18(9):e3000849. PubMed ID: 32898168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors and vectors for SARS-CoV-2 household transmission: a prospective, longitudinal cohort study.
    Derqui N; Koycheva A; Zhou J; Pillay TD; Crone MA; Hakki S; Fenn J; Kundu R; Varro R; Conibear E; Madon KJ; Barnett JL; Houston H; Singanayagam A; Narean JS; Tolosa-Wright MR; Mosscrop L; Rosadas C; Watber P; Anderson C; Parker E; Freemont PS; Ferguson NM; Zambon M; McClure MO; Tedder R; Barclay WS; Dunning J; Taylor GP; Lalvani A;
    Lancet Microbe; 2023 Jun; 4(6):e397-e408. PubMed ID: 37031689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prophylactic intranasal administration of a TLR2/6 agonist reduces upper respiratory tract viral shedding in a SARS-CoV-2 challenge ferret model.
    Proud PC; Tsitoura D; Watson RJ; Chua BY; Aram MJ; Bewley KR; Cavell BE; Cobb R; Dowall S; Fotheringham SA; Ho CMK; Lucas V; Ngabo D; Rayner E; Ryan KA; Slack GS; Thomas S; Wand NI; Yeates P; Demaison C; Zeng W; Holmes I; Jackson DC; Bartlett NW; Mercuri F; Carroll MW
    EBioMedicine; 2021 Jan; 63():103153. PubMed ID: 33279857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upper respiratory tract SARS-CoV-2 RNA loads in symptomatic and asymptomatic children and adults.
    Costa R; Bueno F; Albert E; Torres I; Carbonell-Sahuquillo S; Barrés-Fernández A; Sánchez D; Padrón C; Colomina J; Lázaro Carreño MI; Bretón-Martínez JR; Martínez-Costa C; Navarro D
    Clin Microbiol Infect; 2021 Dec; 27(12):1858.e1-1858.e7. PubMed ID: 34384874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human Nasal and Lung Tissues Infected
    Alfi O; Yakirevitch A; Wald O; Wandel O; Izhar U; Oiknine-Djian E; Nevo Y; Elgavish S; Dagan E; Madgar O; Feinmesser G; Pikarsky E; Bronstein M; Vorontsov O; Jonas W; Ives J; Walter J; Zakay-Rones Z; Oberbaum M; Panet A; Wolf DG
    J Virol; 2021 Jun; 95(14):e0013021. PubMed ID: 33893170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Innate and Adaptive Immune Responses in the Upper Respiratory Tract and the Infectivity of SARS-CoV-2.
    Ramasamy R
    Viruses; 2022 Apr; 14(5):. PubMed ID: 35632675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Upper Respiratory Tract Microbiome Network Impacted by SARS-CoV-2.
    Li W; Ma ZS
    Microb Ecol; 2023 Aug; 86(2):1428-1437. PubMed ID: 36509943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood transcriptional biomarkers of acute viral infection for detection of pre-symptomatic SARS-CoV-2 infection: a nested, case-control diagnostic accuracy study.
    Gupta RK; Rosenheim J; Bell LC; Chandran A; Guerra-Assuncao JA; Pollara G; Whelan M; Artico J; Joy G; Kurdi H; Altmann DM; Boyton RJ; Maini MK; McKnight A; Lambourne J; Cutino-Moguel T; Manisty C; Treibel TA; Moon JC; Chain BM; Noursadeghi M;
    Lancet Microbe; 2021 Oct; 2(10):e508-e517. PubMed ID: 34250515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of interferon response by high viral loads at early stage infection may protect against severe outcomes in COVID-19 patients.
    Rouchka EC; Chariker JH; Alejandro B; Adcock RS; Singhal R; Ramirez J; Palmer KE; Lasnik AB; Carrico R; Arnold FW; Furmanek S; Zhang M; Wolf LA; Waigel S; Zacharias W; Bordon J; Chung D
    Sci Rep; 2021 Aug; 11(1):15715. PubMed ID: 34344959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perspective of the Relationship between the Susceptibility to Initial SARS-CoV-2 Infectivity and Optimal Nasal Conditioning of Inhaled Air.
    Ramasamy R
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.